A Look Into Basic Materials Sector Value Stocks

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the…

What Defines a Value Stock?

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga Insights has compiled a list of value stocks in the basic materials sector that may be worth watching:

  1. Vale (NYSE:VALE) – P/E: 7.57
  2. Origin Mat (NASDAQ:ORGN) – P/E: 2.44
  3. Warrior Met Coal (NYSE:HCC) – P/E: 7.11
  4. Sylvamo (NYSE:SLVM) – P/E: 7.34
  5. Mosaic (NYSE:MOS) – P/E: 9.14

Most recently, Vale reported earnings per share at $0.66, whereas in Q2 earnings per share sat at $0.2. Origin Mat has reported Q3 earnings per share at $0.22, which has increased by 540.0% compared to Q2, which was -0.05. This quarter, Warrior Met Coal experienced an increase in earnings per share, which was $1.63 in Q2 and is now $1.85. Most recently, the company reported a dividend yield of 0.6%, which has decreased by 0.06% from last quarter’s yield of 0.66%.

This quarter, Sylvamo experienced an increase in earnings per share, which was $1.14 in Q2 and is now $1.7. Its most recent dividend yield is at 2.39%, which has decreased by 0.46% from 2.85% in the previous quarter.

Most recently, Mosaic reported earnings per share at $0.68, whereas in Q2 earnings per share sat at $1.04. The company’s most recent dividend yield sits at 2.26%, which has increased by 0.11% from 2.15% last quarter.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Total
0
Shares
Related Posts
Read More

UnitedHealth’s Q1 Medical Cost Update, Prudent Outlook Eases Investor Concerns: Goldman Sachs

UnitedHealth impresses with Q1 results amid the aftermath of the Change Healthcare cyberattack and maintains strong guidance amidst business disruption costs. Goldman Sachs reaffirms Buy rating, citing favorable medical cost updates and prudent outlook, despite cyberattack-related challenges.

UNH